Open AccessThe esophageal dose–volume parameters for predicting Grade I–II acute esophagitis correlated with weight loss and serum albumin decrease in lung cancer radiotherapy
Author(s) -
Zümrüt Arda Kaymak,
Emine Elif Özkan,
Alper Özseven
Publication year - 2021
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_410_19
Subject(s) - medicine , esophagus , esophagitis , nuclear medicine , gastroenterology , rank correlation , radiation therapy , albumin , esophageal cancer , cancer , reflux , mathematics , statistics , disease
Acute esophagitis (AE) is a commonly encountered side effect of curative thoracic radiotherapy (CTRT) for lung cancer patients. Nevertheless, its identification for widely used scoring systems depends on patients' statements. It is aimed to evaluate the correlation between the esophagus doses during CTRT and Grade 1-2 AE, weight change, and change in serum albumin (Alb) levels.